1. Home
  2. SURG vs HOTH Comparison

SURG vs HOTH Comparison

Compare SURG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.55

Market Cap

13.8M

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
HOTH
Founded
2006
2017
Country
United States
United States
Employees
20
3
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
12.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SURG
HOTH
Price
$0.55
$0.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$5.00
AVG Volume (30 Days)
752.4K
3.0M
Earning Date
04-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.69
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.77
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.49
52 Week High
$3.45
$2.12

Technical Indicators

Market Signals
Indicator
SURG
HOTH
Relative Strength Index (RSI) 41.44 40.19
Support Level $0.46 $0.49
Resistance Level $0.94 $0.80
Average True Range (ATR) 0.09 0.05
MACD 0.00 -0.00
Stochastic Oscillator 31.96 3.25

Price Performance

Historical Comparison
SURG
HOTH

About SURG SurgePays Inc.

Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

Share on Social Networks: